Holen Sie sich die Stockscreener-App
3.9594
0.51%
0.0094
Schlusskurs vom Vortag:
$3.95
Offen:
$3.94
24-Stunden-Volumen:
70,032
Relative Volume:
0.41
Marktkapitalisierung:
$26.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.21M
KGV:
-0.1215
EPS:
-32.6
Netto-Cashflow:
$-16.86M
1W Leistung:
+6.43%
1M Leistung:
+3.93%
6M Leistung:
-6.48%
1J Leistung:
-4.57%
1-Tages-Spanne:
$3.81
$4.00
1-Wochen-Bereich:
$3.57
$4.00
52-Wochen-Spanne:
$3.20
$6.01
Cingulate Inc Stock (CING) Company Profile
Firmenname
Cingulate Inc
Sektor
Branche
Telefon
(913) 942-2300
Adresse
1901 W. 47TH PLACE, KANSAS CITY
Vergleichen Sie CING mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
3.98 | 26.62M | 0 | -21.21M | -16.86M | -32.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.70 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.46 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
457.57 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
898.33 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.44 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2023-12-22 | Herabstufung | Laidlaw | Buy → Hold |
Cingulate Inc Aktie (CING) Neueste Nachrichten
Can Cingulate Inc. Equity Warrant stock deliver surprise earnings beatMarket Growth Report & Stepwise Trade Signal Implementation - Newser
Will Cingulate Inc. stock attract more institutional investorsPortfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
How strong is Cingulate Inc. stock balance sheetCEO Change & Accurate Intraday Trade Tips - Newser
Cingulate Inc. (NASDAQ:CING) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Cingulate Inc Stock Analysis and ForecastEnergy Sector Updates & Chat With Other Investors on Daily Signals - earlytimes.in
Cingulate Inc Equity Warrant Stock Analysis and ForecastMarket Sentiment Shifts & High Profit Trading Plans - earlytimes.in
Will Cingulate Inc. stock maintain dividend yieldEarnings Recap Summary & Precise Buy Zone Tips - moha.gov.vn
Will Cingulate Inc. stock return to pre crisis levelsPortfolio Return Summary & Consistent Growth Equity Picks - BỘ NỘI VỤ
Sentiment Recap: Will Cingulate Inc. stock gain from lower inflation2025 Major Catalysts & High Accuracy Swing Entry Alerts - BỘ NỘI VỤ
Is There NearTerm Timing Risk on India Glycols Limited StockPrice Momentum Alerts & Big Gains Low Investment - earlytimes.in
Press Release: Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update - 富途牛牛
Is Cingulate Inc. Equity Warrant stock dividend yield sustainable - newser.com
Zacks Small Cap Lowers Earnings Estimates for Cingulate - Defense World
Cingulate price target lowered to $16 from $17 at Roth Capital - Yahoo Finance
Why Cingulate Inc. Equity Warrant stock remains on buy listsPortfolio Return Report & Safe Entry Zone Identification - newser.com
Will breakout in Cingulate Inc. Equity Warrant lead to full recoveryJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
What data driven models say about Cingulate Inc.’s futureMarket Sentiment Report & Short-Term High Return Strategies - newser.com
How Cingulate Inc. stock performs in high volatility markets2025 EndofYear Setup & Safe Entry Zone Tips - newser.com
Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year - MSN
Signal strength of Cingulate Inc. stock in tech scannersWeekly Trend Recap & Real-Time Stock Entry Alerts - newser.com
Will Cingulate Inc. Equity Warrant stock recover faster than marketJuly 2025 Patterns & Capital Efficiency Focused Ideas - newser.com
Published on: 2025-11-19 18:10:29 - newser.com
Can Cingulate Inc. Equity Warrant stock deliver consistent earnings growth - newser.com
Strategies to average down on Cingulate Inc. Equity Warrant2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Is Cingulate Inc. Equity Warrant stock in correction or buying zoneJuly 2025 Levels & AI Based Buy and Sell Signals - newser.com
Roth Capital Maintains Cingulate (CING) Buy Recommendation - Nasdaq
Is Cingulate Inc. stock ready for a breakoutJuly 2025 Recap & Community Verified Trade Signals - newser.com
Published on: 2025-11-19 05:53:07 - newser.com
Can Cingulate Inc. stock sustain revenue growthTrade Entry Report & Safe Entry Trade Signal Reports - newser.com
Cingulate Advances ADHD Treatment CTx-1301 Toward Potential 2026 FDA Approval - citybuzz
Does Cingulate Inc. fit your quant trading modelQuarterly Portfolio Report & Target Return Focused Picks - newser.com
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25 - TradingView
Cingulate (NASDAQ: CING) Gains FDA Acceptance of CTx-1301 NDA, Eyes ADHD Launch - Stock Titan
How to use a screener to detect Cingulate Inc. breakoutsJuly 2025 Levels & Real-Time Stock Entry Alerts - newser.com
Published on: 2025-11-17 14:33:47 - newser.com
CING: Third Quarter Results - Yahoo Finance
Price action breakdown for Cingulate Inc.July 2025 Recap & High Conviction Buy Zone Picks - newser.com
Can Cingulate Inc. stock deliver consistent earnings growth2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com
Finanzdaten der Cingulate Inc-Aktie (CING)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):